Cargando…

Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients

INTRODUCTION: Persistent detection of SARS-CoV-2 viral particles has been seen in the absence of symptoms in other solid organ transplant recipients. We report this unique phenomenon in lung transplant (LTx) recipients. CASE REPORT: We present the following cases of prolonged viral shedding in 3 LTx...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, M.T., Mohamed, H., Walia, R., Arjuna, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988589/
http://dx.doi.org/10.1016/j.healun.2022.01.689
_version_ 1784682995274219520
author Olson, M.T.
Mohamed, H.
Walia, R.
Arjuna, A.
author_facet Olson, M.T.
Mohamed, H.
Walia, R.
Arjuna, A.
author_sort Olson, M.T.
collection PubMed
description INTRODUCTION: Persistent detection of SARS-CoV-2 viral particles has been seen in the absence of symptoms in other solid organ transplant recipients. We report this unique phenomenon in lung transplant (LTx) recipients. CASE REPORT: We present the following cases of prolonged viral shedding in 3 LTx recipients: Patient A - 68-year-old female, bilateral LTx recipient for COPD (02/2020), Patient B - 65-year-old male, bilateral LTx recipient for IPF (07/2020), and Patient C - 64-year-old female, bilateral LTx recipient for COPD (08/2020). There were no major intraoperative complications, and the maintenance immunosuppression regimen was the same across patients. Patient A contracted COVID-19 at our center 10 months after transplant, reporting upper respiratory infection symptoms, after initially presenting with persistent headaches and diagnosed with posterior reversible encephalopathy syndrome. Patients B and C presented to clinic with myalgias and mild dyspnea at one and five months after transplant, respectively. SARS-CoV-2 was detected by RT-PCR of nasopharyngeal specimens in all patients. Chest CT demonstrated typical findings of COVID-19 pneumonia in all patients. Patients A and C received remdesivir and belatacept and were discharged home on days 5 and 7, respectively; Patient B received remdesivir and convalescent plasma and was discharged home on day 8. All were in stable clinical condition on room air. All 3 patients had persistently positive nasopharyngeal swab samples up to four weeks after hospitalization, despite absence of symptoms. We did not augment immunosuppression in these patients. Imaging findings during and after the infectious course are shown in Figure 1. Patient C has persistent lower lobe radiographic changes after COVID-19. SUMMARY: LTx recipients may exhibit prolonged viral shedding up to at least 1 month despite resolution of symptoms. Well-established cohort studies are needed to elucidate the full duration of viral shedding in this group.
format Online
Article
Text
id pubmed-8988589
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89885892022-04-11 Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients Olson, M.T. Mohamed, H. Walia, R. Arjuna, A. J Heart Lung Transplant (668) INTRODUCTION: Persistent detection of SARS-CoV-2 viral particles has been seen in the absence of symptoms in other solid organ transplant recipients. We report this unique phenomenon in lung transplant (LTx) recipients. CASE REPORT: We present the following cases of prolonged viral shedding in 3 LTx recipients: Patient A - 68-year-old female, bilateral LTx recipient for COPD (02/2020), Patient B - 65-year-old male, bilateral LTx recipient for IPF (07/2020), and Patient C - 64-year-old female, bilateral LTx recipient for COPD (08/2020). There were no major intraoperative complications, and the maintenance immunosuppression regimen was the same across patients. Patient A contracted COVID-19 at our center 10 months after transplant, reporting upper respiratory infection symptoms, after initially presenting with persistent headaches and diagnosed with posterior reversible encephalopathy syndrome. Patients B and C presented to clinic with myalgias and mild dyspnea at one and five months after transplant, respectively. SARS-CoV-2 was detected by RT-PCR of nasopharyngeal specimens in all patients. Chest CT demonstrated typical findings of COVID-19 pneumonia in all patients. Patients A and C received remdesivir and belatacept and were discharged home on days 5 and 7, respectively; Patient B received remdesivir and convalescent plasma and was discharged home on day 8. All were in stable clinical condition on room air. All 3 patients had persistently positive nasopharyngeal swab samples up to four weeks after hospitalization, despite absence of symptoms. We did not augment immunosuppression in these patients. Imaging findings during and after the infectious course are shown in Figure 1. Patient C has persistent lower lobe radiographic changes after COVID-19. SUMMARY: LTx recipients may exhibit prolonged viral shedding up to at least 1 month despite resolution of symptoms. Well-established cohort studies are needed to elucidate the full duration of viral shedding in this group. Published by Elsevier Inc. 2022-04 2022-04-07 /pmc/articles/PMC8988589/ http://dx.doi.org/10.1016/j.healun.2022.01.689 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle (668)
Olson, M.T.
Mohamed, H.
Walia, R.
Arjuna, A.
Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients
title Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients
title_full Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients
title_fullStr Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients
title_full_unstemmed Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients
title_short Persistent Viral Detection After Resolution of COVID-19 in Lung Transplant Recipients
title_sort persistent viral detection after resolution of covid-19 in lung transplant recipients
topic (668)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988589/
http://dx.doi.org/10.1016/j.healun.2022.01.689
work_keys_str_mv AT olsonmt persistentviraldetectionafterresolutionofcovid19inlungtransplantrecipients
AT mohamedh persistentviraldetectionafterresolutionofcovid19inlungtransplantrecipients
AT waliar persistentviraldetectionafterresolutionofcovid19inlungtransplantrecipients
AT arjunaa persistentviraldetectionafterresolutionofcovid19inlungtransplantrecipients